The divergent effects of SphK1−/− or SphK2−/− on the maintenance of the vascular endothelial barrier and the severity of kidney injury during renal inflammation prompted us to investigate their roles in the development of HUS. This evidence concerns the gene SPHK1 and hemolytic-uremic syndrome.